Canada — Bharat WorldMeds

India ships $673M in pharmaceutical products to Canada each year, making it the #9 export destination. Both countries track this trade: Stats Canada import data confirms the scale. The vast majority are finished medicines — drug formulations ready for dispensing.

Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Jan–Dec). Stats Canada records what Canada imports from India. DGCIS records what India exports to Canada. Category and product detail from DGCIS.

$673M

Scale

India supplies $673M in pharmaceutical products to Canada each year — a substantial supply line of affordable medicine.

86%

Medicine

Overwhelmingly finished medicines — drug formulations account for 86% of shipments.

4.7×

Trajectory

Rapid expansion: Canada's imports of Indian pharmaceutical products have grown 4.7× over the past decade, from $142M to $673M.

Context

A top-10 export destination, and a key pharmaceutical market in Americas.

✦

Impact

Indian pharmaceutical companies have both exported to and invested directly in Canada — building trade and operational presence.

$629M

Ranking Basis

India's official export data (DGCIS, FY 2025–26) records $629M in pharmaceutical products to Canada — the figure behind the #9 ranking.

Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more

Medicines $541M (86.0%) Medicine Ingredients $70.1M (11.1%) Traditional & Herbal $12.4M (2.0%) Surgical & Hospital Supplies $3.6M (0.6%) Vaccines $1.7M (0.3%)

Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $71.5M in active pharmaceutical ingredients and bulk drugs to Canada in 2025 (India-reported, DGCIS).

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Canada: $425M across 81 filings (2011-2026).